Home

International quality assurance - all Huvitz products are certified by the international quality assurance system.

Euro-Optics are committed to bringing practitioners the latest internationally renowned optical instrument and equipment at highly competitive prices.

Our products are with cutting edge technology of the future which makes them one of the worlds most reliable and accurate instruments and is backed by factory trained technicians.

All instruments have the CE, FDA, ISO 9002, TUV and Canadian Quality Certificates

Contact Us on either of these numbers

Rihaz: 082 414 1472
Faisal: 079 242 2817

If not we are available, please WhatsApp your request to us

For quotations please send email to This email address is being protected from spambots. You need JavaScript enabled to view it.
and cc to This email address is being protected from spambots. You need JavaScript enabled to view it.

For personal information send only to This email address is being protected from spambots. You need JavaScript enabled to view it.

For additional assistance email This email address is being protected from spambots. You need JavaScript enabled to view it.

We are proud to announce that Espansione Group's propietary eye-light® platform has been offically recognized in the TFOS DEWS III Management and Therapy Report, the global gold standard in dry eye disease care.

Published in the American Journal of Ophthalmology, the TFOS DEWS III Report acknowledges Photobiomodulation Low-level Light Therapy (LLLT) — delivered through our eye-light® device — as an effective, evidence-backed approach for managing tear film instability, meibomian gland dysfunction, and inflammatory conditions of the ocular surface.

Key Highlights:

eye-light® is recognized as validated therapeutic tool for improving tear film stability and supporting DED management
LLLT can be applied directly to the eyelids — safely across all skin types — and is shown to improve both symptoms and tear volume.
Combined IPL + LLLT therapy using eye-light® demonstrated significant improvements in OSDI score, MGD grading and TBUT (Source Stonecipher et al., 2019; Giannaccare et al., 2023)
Blue LLLT reduces lid-margin bacterial load, offering potential in managing blepharitis and biofilm-related inflammation

Why It Matters

Being featured in the TFOS DEWS III Report is a powerful endorsement of our platform and a meaningful step forward in our mission to redefine how ocular surface diseases are managed — non-invasively and effectively.

Want to know more?

Access the full-length publication on American Journal of Ophthalmology
and Access the Full Press Release.

Keep in touch on our social media and visit our website for the
latest news from the forefront of medtech innovation.

Categories

Home

Off Canvas Menu